← Back to Screener
Organigram Global Inc. Common Shares (OGI)
Price$1.52
Favorite Metrics
Price vs S&P 500 (26W)-31.10%
Price vs S&P 500 (4W)3.13%
Market Capitalization$209.84M
All Metrics
Book Value / Share (Quarterly)$1.99
P/TBV (Annual)1.26x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)21.14%
Cash Flow / Share (Quarterly)$-0.20
Price vs S&P 500 (YTD)-12.15%
Gross Margin (TTM)8.13%
Net Profit Margin (TTM)6.49%
EPS (TTM)$0.10
10-Day Avg Trading Volume0.11M
EPS Excl Extra (TTM)$0.10
Revenue Growth (5Y)24.46%
EPS (Annual)$-0.14
ROI (Annual)-5.80%
Gross Margin (Annual)6.64%
Net Profit Margin (5Y Avg)-73.33%
Cash / Share (Quarterly)$0.05
P/E Basic Excl Extra (TTM)15.83x
Revenue Growth QoQ (YoY)48.70%
ROA (Last FY)-4.40%
Revenue Growth TTM (YoY)68.55%
EBITD / Share (TTM)$0.01
ROE (5Y Avg)-28.70%
Operating Margin (TTM)-5.57%
Cash Flow / Share (Annual)$-0.13
P/B Ratio0.78x
P/B Ratio (Quarterly)0.85x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)1.23x
Net Interest Coverage (TTM)-0.46x
ROA (TTM)3.31%
EV / EBITDA (TTM)236.94x
EPS Incl Extra (Annual)$-0.14
Current Ratio (Annual)2.26x
Quick Ratio (Quarterly)1.20x
3-Month Avg Trading Volume0.29M
52-Week Price Return41.78%
P/E Incl Extra (TTM)15.83x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$1.74
P/S Ratio (Annual)1.11x
Asset Turnover (Annual)0.46x
52-Week High$3.09
Operating Margin (5Y Avg)-67.17%
EPS Excl Extra (Annual)$-0.14
CapEx CAGR (5Y)-26.35%
Tangible BV CAGR (5Y)0.20%
26-Week Price Return-27.11%
Quick Ratio (Annual)1.18x
13-Week Price Return-8.00%
Total Debt / Equity (Annual)0.22x
Current Ratio (Quarterly)2.73x
Enterprise Value$250.615
Revenue / Share Growth (5Y)0.21%
Asset Turnover (TTM)0.51x
Book Value / Share Growth (5Y)-15.88%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.34x
Pretax Margin (Annual)-14.87%
Cash / Share (Annual)$0.16
3-Month Return Std Dev54.16%
Gross Margin (5Y Avg)-10.28%
Net Income / Employee (TTM)$0
ROE (Last FY)-7.09%
Net Interest Coverage (Annual)-0.10x
EPS Basic Excl Extra (Annual)$-0.14
P/FCF (TTM)3.54x
Receivables Turnover (TTM)6.25x
Total Debt / Equity (Quarterly)0.17x
EPS Incl Extra (TTM)$0.10
Receivables Turnover (Annual)5.39x
ROI (TTM)4.19%
P/S Ratio (TTM)1.03x
Pretax Margin (5Y Avg)-74.88%
Revenue / Share (Annual)$1.48
Tangible BV / Share (Annual)$1.63
Forward P/E14.26x
Price vs S&P 500 (52W)11.95%
P/E Ratio (TTM)15.83x
Year-to-Date Return-10.39%
5-Day Price Return6.98%
EPS Normalized (Annual)$-0.14
ROA (5Y Avg)-24.98%
Net Profit Margin (Annual)-9.55%
Month-to-Date Return11.89%
Cash Flow / Share (TTM)$-1.85
EBITD / Share (Annual)$-0.03
Operating Margin (Annual)-8.44%
LT Debt / Equity (Annual)0.20x
ROI (5Y Avg)-27.78%
P/E Excl Extra (TTM)15.83x
LT Debt / Equity (Quarterly)0.15x
EPS Basic Excl Extra (TTM)$0.10
P/TBV (Quarterly)0.97x
P/B Ratio (Annual)1.08x
Inventory Turnover (TTM)2.17x
Pretax Margin (TTM)1.57%
Book Value / Share (Annual)$1.89
Price vs S&P 500 (13W)-8.69%
Beta1.62x
Revenue / Share (TTM)$1.49
ROE (TTM)4.86%
52-Week Low$1.37
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.88
3.89
3.89
3.89
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
OGIOrganigram Global Inc. Common Shares | 1.03x | 68.55% | 8.13% | — | $1.52 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Organigram Global Inc is a licensed cannabis cultivator and manufacturer focused on Canada's adult recreational market, operating production facilities in Moncton, New Brunswick, Lac-Supérieur, Quebec, and a dedicated edibles facility in Winnipeg, Manitoba. The company maintains a diversified brand portfolio including Edison, SHRED, Monjour, and multiple other consumer-facing brands across cannabis and cannabis-derived products.